MY ACCOUNT | NEWSLETTER |
 
 

Search

8 Results found


FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

Like0
Dislike0

FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

FDA Approves Temporary Drug Importation

Like0
Dislike0

Chance's normal dog life: An update on his heart condition

Like0
Dislike0

AVMA webinar outlines FDA guidance on compounding drugs

Like0
Dislike0

FDA conditionally approves chemo-induced diarrhea treatment for dogs

Like0
Dislike0

FDA approved lymphoma therapy for canines

Like0
Dislike0
Page of 1        1  

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top